Review: risk for cardiovascular events is increased with rofecoxib, diclofenac, and indomethacin but not celecoxib

  • Colin P Bradley

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)24
JournalACP Journal Club
Volume146
Issue number1
Publication statusPublished - 2007
Externally publishedYes

Cite this